General License Terms. The Product is licensed, not sold, to you by us under the terms of this XXXX and the Order. The scope of license granted by us to you for the Product is set out in section 3 (Product Family Specific Terms) and section 4 (Product Specific Terms).
General License Terms. 10.1 The registration of the Software and the right of use are bound to the User and cannot be transferred or sublicensed to third parties without the Licensor‘s prior consent. If the applicable license model provides that the license is personalized and allo- cated to a specific named-user, the right of use may only be transferred to another named user if the Licensor is informed by the User and agreed to such transfer. Any transfer of the right of use must be documented by the Licensor, the User and the third party assignee. Details regarding the transfer process are provided on the Licensor’s Website. Certain license models do not allow any transfer or assignment of the right of use.
General License Terms. All software license rights that we grant you are specifically subject to the following general terms and conditions:
General License Terms. 2.1 Subject to the terms of DIR Contract No. DIR-TSO-3480, these General Terms and each applicable Product Exhibit, Proofpoint grants to Customer and its Affiliates a royalty-free, non-exclusive, limited term, non-transferable (except to a successor in interest as permitted hereunder) license to use the Proofpoint Products purchased by Customer during the Term in accordance with the Documentation, in the quantities specified in the applicable Order Form, and solely for Customer’s own internal business purposes. Customer may use the Documentation in connection with the license granted hereunder.
General License Terms. Each Font Software may include additional terms or conditions that you are required to accept before downloading or installing, and those terms or conditions are incorporated into this XXXX. Vectro reserves the right to decline to license Font Software to any party at Vectro’s sole discretion. All licenses granted by Vectro under this XXXX are personal, worldwide, royalty free, nonassignable, non sublicensable, revocable, and nonexclusive. Except as provided in this XXXX, you shall not: (i) transfer, give access to, or distribute any part of any Font Software to any third-party without Vectro’s prior written consent; (ii) attempt to reverse engineer, alter, or modify any part of any Font Software; (iii) attempt in any way to emulate, mimic, or otherwise create a substitute for any Font Software, including outlining; or (v) use the Font Software in any way not expressly permitted in this XXXX. Commercial License A commercial license is required if the Font Software will be used by: (i) a business or organization, even if the project, or usage, has no direct financial value; or (ii) an individual if the project or usage has a financial incentive, even indirectly. A commercial license must be purchased that accurately reflects the number of employees, not including subcontractors, in the business or organization listed as the end user during checkout (“End User”), even if they will not be installing the Font Software. If you choose and pay for this license category during checkout, you may use the Font Software as stated in this section. Upon our receipt of the applicable payment, Vectro grants you a nonexclusive, royalty free, perpetual, worldwide, and nonassignable license to use the Font Software as stated in this section. A commercial license permits the following usage of the provided Font Software:
General License Terms. 2.4.1 Licensee may:
General License Terms. Kronos owns or has the right to license the Software. The Software and Software documentation are confidential and may not be disclosed to a third party without Kronos’ written consent. The Software contains proprietary trade secret technology. Unauthorized use and copying of such Software is proh bited by law, including United States and foreign copyright law. The price Customer pays for a copy of the Software constitutes a license fee that entitles Customer to use the Software as set forth below. Kronos grants to Customer a non-exclusive, nontransferable, perpetual (except as provided herein) license to use the Software. This license may be terminated by Kronos by written notice to Customer upon any material breach of this Agreement by Customer which remains uncured for a period of thirty (30) days after such written notice from Kronos. Upon such termination of this license by Kronos, Customer will have no further right to use the Software and will return the Software media to Kronos and destroy all copies of the Software (and related documentation) in Customer’s possession or control. This license is subject to all of the terms of this Section B.
General License Terms. 2.2.1. Updates or other minor enhancements of the Software are available as part of Support Services.
General License Terms. A) This Section applies to all licenses granted under this SLA. Licenses are non-transferable and non-exclusive. Use of each license is limited to the designated Licensee, Site(s), Project, and Licensed Platform(s) and to the License Term, all as defined in the LAC specifying the grant. For each license, Licensee must pay RTI fees in accordance with RTI’s then-current, applicable, published price list, or as may be specifically agreed to in writing between Licensee and RTI. If Licensee elects to use the Software outside of the License Term, Licensee will need to acquire an appropriate license. For all licenses with a specified numerical limit, Licensee agrees to provide RTI with good-faith estimates of actual license usage annually. Licensee may make a reasonable number of copies of the Software strictly for backup or archival purposes. Any such backup copy shall remain RTI’s exclusive property and must include all copyright or other proprietary rights notices contained in the original.
General License Terms. Each license agreement resulting from the exercise of an Option pursuant to Section 6.4 shall include, among other things: (a) in the case of an exclusive license, terms consistent with the provisions of 35 USC §§ 200-212 and 37 CFR § 401 et seq., and a reservation of the rights of WCM and other not-for-profit research organizations to practice the subject matter of the licensed WCM Patent Rights, Joint Patent Rights, WCM Results and Joint Results for research, teaching and other educational purposes only; (b) indemnity, insurance, limitations on liability, patent cost reimbursement and other provisions customary to patent and technology licenses normally granted by WCM; (c) commercially reasonable due diligence obligations for the development and commercialization of products or processes covered by the relevant WCM Patent Rights and/or Joint Patent Rights; (d) [***] that are commercially reasonable for licenses from an academic institution to a biotechnology or drug discovery company at a similar stage of development as Company; and (e) the obligation of Company to [***].
